Gene therapy

Gene Therapy

Gene therapy is undoubtedly one of the most radical developments in modern medicine. It is a technique to alter the genes inside an individual’s cells, which helps to treat or prevent diseases.

In other words, gene therapy provides an opportunity to find cures for certain diseases that, until recently, were believed to be incurable. With improved understanding of genetics and biotechnology, gene therapy is fast moving from the realm of a theoretical possibility into that of a practical and increasingly common medical treatment.

Recently, the USFDA has approved gene therapy for sickle-cell anemia and beta-thalassemia

What is Gene Therapy?


What is gene therapy Gene therapy

Gene therapy is the technique of introducing genes into a patient—either to modify the genes or to remove or introduce genetic material to the patient’s cells to counteract or prevent a disease. It typically works by correcting genes that are malfunctioning and contributing to the disease course. There may be several ways of doing this, such as:

Replacing the Mutated Gene: A healthy copy of the gene is introduced to a cell. It replaces a disease-causing mutated gene.
Inactivating the Mutated Gene: A gene that misbehaves is rendered inactive.

Introduction of a New or Modified Gene: Introduce new genes into the body, that supplement the gene function to cure the disease.

These can be done in vivo, where genes are introduced directly to the patient’s body, or ex vivo, where genes are modified outside the body and then introduced into it.

How does Gene Therapy work?

Gene therapy usually utilizes a vector, most often a virus, to convey the corrective gene into the cells of the patient. These vectors are rebuilt to be harmless. Targeting of particular cells is attained by the use of specialized vectors. After entering the cells, the new gene will either begin to produce the correct proteins or block the function of the malfunctioning gene.

For instance, a gene may be introduced in the lungs in genetic disorders like cystic fibrosis to make the right protein, which the mutated gene is unable to produce. Genes are transferred in cancer treatment to provide an avenue where the cancer cells could be killed by chemotherapy or to stimulate the immune system to attack the cancerous cells.


Gene therapy can be beneficial for many diseases, particularly those caused by single-gene defects.

These include:

Genetic Disorders: Cystic fibrosis, hemophilia, muscular dystrophy, and sickle cell anemia are some of the diseases that can be treated or even cured with gene therapy, provided the defective genes causing these diseases are rectified.

Gene therapy is used for treating cancer, which makes the cancer cells. Additionally, gene therapy might work via the insertion of genes into a patient’s cells, making them more vulnerable to chemotherapy or enhancing the immune system’s ability to fight cancer.

Viral Infections: Gene therapy can help in treating viral infections by introducing genes that may fight off the viruses more effectively.

Success Stories
Several gene therapy successes have gained employment for greater acceptance and application.

These include: 

Severe Combined Immunodeficiency: Also known as the “bubble boy” disease, SCID was the first disease to be successfully treated by gene therapy. SCID patients are born without a functioning immune system. Gene therapy has offered a procedure to correct defective genes in these patients and has given them the chance to lead a normal life.
Leber’s Congenital Amaurosis: Gene therapy has been used to treat this inherited blindness. Patients who otherwise would have remained blind now start to show some vision.
Spinal Muscular Atrophy: This is a fatal genetic disorder in infants, that has been treated by gene therapy and has shown promising results with improvements in motor function and heightened survival rates.

Where Is It Available?

Currently, gene therapy is available as a USFDA-approved product in the USA and is offered in clinical trials in China. Gene therapy is approved by the USFDA for sickle-cell anemia and beta-thalassemia. 

Gene therapy presently caters to a spectrum of ailments, encompassing spinal muscular atrophy (SMA), specific hereditary visual impairments, and distinct cancer variants like acute lymphoblastic leukemia (ALL). The endorsement of these interventions by entities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) signifies a notable stride in rendering these therapies accessible to individuals.

Notwithstanding its potential, the extensive availability of gene therapy remains constrained by exorbitant expenses, intricate production procedures, and the necessity for specialized medical facilities. Furthermore, ethical deliberations and enduring safety apprehensions necessitate continual exploration and regulatory examination.

With technological progressions and plausible cost reductions, the future landscape of gene therapy appears auspicious, poised to transform the treatment domain for a plethora of genetic disorders, presenting patients with fresh prospects for optimism and enhanced health outcomes.

Challenges and Ethical Considerations

Gene therapy, even with all its potential, still faces many challenges.

Safety: Many potential risks arise just because new genes are being introduced into a body, and they include gene alterations that have side effects or infect other genes, an immune response against the new genes, and acquired secondary disorders. One of the gigantic barriers to the implementation of genes for therapy is ensuring that the therapeutic gene is delivered to the right cells and works appropriately. Gene therapies are very expensive and thus unaffordable for so many patients in need of treatment. Another major consideration in gene therapy development and application is ethics.

For example:

Germline Therapy: Genetic manipulation in germ cells (sperm or eggs) is ethically questionable because changes would be passed on to future generations, hence affecting the gene pool of the human race.
Access and Equity: Gene therapy access should be such that it provides access to everybody; there should not be any disparity in this kind of health care.

Future of Gene Therapy

The future of gene therapy is amazingly bright. Here, rapid progress is being made in technologies that include genome editing by CRISPR-Cas9—one of the new and powerful tools for the purpose of the precise editing of genes. Now, gene therapy can cure genetic diseases, enhance the efficacy for cancer treatments, and fight viral infections.

This next generation treatment method will become very mainstream as research continues and multiple clinical trials are conducted. With proper regulation, ethical considerations, and equity in access, this therapy has the potential to revolutionize the way of treatment for various diseases, offering hope to millions of patients around the world.


Gene therapy is seen to be a very bright hope in the arena of modern medicine, having the capability and potential to treat and even cure diseases that long remained untreatable. It is in that sense that gene therapy still holds out a promise to alter health care, open the gateway to precision medicines, and further personalized treatments, since new breakthroughs into the human genome and betterment of genetic engineering techniques are yet to be realized. A challenging journey lies ahead, no doubt; but reading through the lines, what gene therapy promises to achieve makes it one of the most interesting areas of contemporary medicine.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy